DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Alimta (Pemetrexed Disodium) - Current Clinical Trials

 
 



Alimta Related Clinical Trials

Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer [Active, not recruiting]

Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer [Completed]

Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) [Completed]

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma [Completed]

Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer [Recruiting]

Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer [Completed]

Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC) [Completed]

Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate [Terminated]

A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding Phase [Completed]

Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma [Withdrawn]

ZD6474(Vandetanib) + Alimta Combo Study [Completed]

Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer [Completed]

Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed) [Recruiting]

Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer [Completed]

Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer [Completed]

Pemetrexed Plus Gemcitabine in Renal Cell Cancer [Terminated]

Abraxane and Alimta in Advanced Solid Tumors [Completed]

Intraperitoneal Pemetrexed, Cisplatin, and Paclitaxel as First-Line Therapy in Treating Women With Stage III Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Completed]

Pemetrexed in Advanced Non-Small-Cell Lung Cancer: at Progression vs Maintenance Therapy After Induction Chemotherapy [Recruiting]

Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer [Active, not recruiting]

Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy [Completed]

TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer [Terminated]

NovoTTF-100L in Combination With Pemetrexed (Alimta�) for Advanced Non-small Cell Lung Cancer [Completed]

Alimta and Gemcitabine in Non-Small Cell Lung Cancer [Completed]

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas. [Completed]

Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma [Terminated]

Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen [Completed]

A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients [Completed]

Pemetrexed (ALIMTA) and Gefitinib (IRESSA�) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy [Enrolling by invitation]

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer [Completed]

Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer [Terminated]

Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2 [Completed]

Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors [Suspended]

Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer [Completed]

Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases [Active, not recruiting]

Modufolin (6R 5,10-Methylenetetrahydrofolate) and Pemetrexed for Neoadjuvant Rectal Cancer Treatment [Completed]

Study of TRC102 in Combination With Pemetrexed in Cancer Patients [Completed]

Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors [Active, not recruiting]

Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma [Completed]

Study of Pemetrexed Versus Pemetrexed Plus Erlotinib as Treatment of Nonsquamous Non-Small Cell Lung Cancer (NSCLC) [Completed]

Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC [Active, not recruiting]

Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment [Completed]

Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC) [Completed]

PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer [Active, not recruiting]

Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer [Recruiting]

Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) [Recruiting]

A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors [Completed]

Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer [Completed]

Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung Cancer [Recruiting]

Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer [Terminated]

Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer [Terminated]

Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer [Completed]

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Active, not recruiting]

An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations [Active, not recruiting]

High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases [Not yet recruiting]

Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma [Completed]

BIBF 1120 in Combination With Pemetrexed in Advanced Non Small Cell Lung Cancer (NSCLC) [Completed]

Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma [Recruiting]

Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC [Recruiting]

A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population [Terminated]

Safety of Everolimus and Pemetrexed in Lung Cancer Patients [Completed]

Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck [Recruiting]

Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer [Active, not recruiting]

Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations [Completed]

Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors [Active, not recruiting]

Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC) [Completed]

A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC [Completed]

ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. [Completed]

Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases [Completed]

ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer [Completed]

Pemetrexed Followed by Docetaxel or in Reverse Sequence [Completed]

Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer [Recruiting]

Alimta Plus Gemcitabine for Advanced Sarcoma [Completed]

Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer [Recruiting]

Pemetrexed and Carboplatin in Recurrent Platinum Sensitive Ovarian Cancer [Recruiting]

A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC) [Completed]

Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [Completed]

S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Terminated]

A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC) [Active, not recruiting]

Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma [Active, not recruiting]

Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer [Completed]

Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer [Recruiting]

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma [Completed]

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors [Completed]

A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer [Completed]

Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer [Completed]

Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors [Completed]

AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma [Withdrawn]

Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer [Active, not recruiting]

A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC [Recruiting]

Phase II Trial of Bevacizumab in Combination With Pemetrexed as 2nd Line Therapy in Patients With Stable Brain Metastases From Non-small Cell Lung Cancer [Active, not recruiting]

Stage IV Colorectal CA ALIMTA [Completed]

Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer [Terminated]

Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib [Terminated]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015